Screening Age Debate Intensifies

The death of Olympic cyclist Ciara Mageean has renewed pressure on Irish health officials to adjust national screening protocols.

Mageean died over the weekend at the age of 34. She had publicly disclosed in early 2026 that she was diagnosed with stage four bowel cancer. Her family confirmed her passing via Instagram, noting she was surrounded by loved ones. The statement included the Irish phrase "Ar dheis Dé go raibh a hanam."

Brendan Donlon, the chair of Bowel Cancer Ireland, spoke to RTÉ Radio on Sunday. He noted that the current Bu the BowelScreen program only covers individuals aged 50 to 71. However, only one in ten bowel cancer diagnoses in Ireland involves a person under 50. The charity is currently asking the government to lower the national screening age, which stands at 57.

Donlon emphasized that the health minister supports lowering the age but cited a lack of specific timelines or budget allocations. He stated that increased colonoscopy capacity is required to accommodate more patients. Last year, 6,700 people sought urgent referrals, despite a recommended waiting time of four weeks.

The charity chair advised the public to monitor specific symptoms. He identified blood in the stool as the primary warning sign, describing it as potentially bright red, very dark, or nearly black. He recommended that individuals contact their general practitioner if they experience persistent stomach pain, unexplained weight loss, bloating, or fatigue lasting more than three weeks.

Donlon mentioned that many women in the charity's support group were previously told their symptoms were attributed to IBS or PMS. He urged patients to seek further investigation if they feel their concerns are not taken seriously. He recalled that Mageean contacted the charity after her diagnosis to ask how she could help spread awareness. He stated that her death serves as a reminder that age and fitness do not guarantee immunity from the disease.

BowelScreen offers a free at-home test every two years for eligible residents. The screening is designed to detect potential signs of bowel cancer before symptoms develop. Early detection is associated with better patient outcomes, while later stages present more severe challenges for treatment.